The greater cardiology community was hopeful ZEUS could open the door for significant improvements in patient care. After the trial failed to deliver on that promise, it's time to consider where things went wrong. The greater cardiology community was hopeful ZEUS could open the door for significant improvements in patient care. After the trial failed to deliver on that promise, it's time to consider where things went wrong. | | |
|
GLP-1 receptor agonists have been associated with a wide range of potential benefits for patients with and without type 2 diabetes. The team behind this new meta-analysis hoped to learn more about how the popular medications may impact a person's risk of new-onset AFib. GLP-1 receptor agonists have been associated with a wide range of potential benefits for patients with and without type 2 diabetes. The team behind this new meta-analysis hoped to learn more about how the popular medications may impact a person's risk of new-onset AFib. | | |
|
The FDA has categorized this as a Class I recall. However, patients can still use the devices as long as they follow specific instructions provided by the manufacturer. The FDA has categorized this as a Class I recall. However, patients can still use the devices as long as they follow specific instructions provided by the manufacturer. | | |
|
In-hospital outcomes were slightly better for patients treated with TAVR, but the five-year data linked SAVR to key benefits. In-hospital outcomes were slightly better for patients treated with TAVR, but the five-year data linked SAVR to key benefits. | | |
|
|
Contego Medical secured the new approvals after the FDA reviewed positive data from the PERFORMANCE III IDE study. Contego Medical secured the new approvals after the FDA reviewed positive data from the PERFORMANCE III IDE study. | | |
|
Cardiologist Philippe Généreux spoke to Cardiovascular Business about the highly anticipated PROGRESS trial. "What we learned from this trial is that moderate aortic stenosis should not be seen anymore as a benign entity," he said. Cardiologist Philippe Généreux spoke to Cardiovascular Business about the highly anticipated PROGRESS trial. "What we learned from this trial is that moderate aortic stenosis should not be seen anymore as a benign entity," he said. | | |
|
The Massachusetts clinician went missing after going on an afternoon bike ride. Authorities found his body the following day. The Massachusetts clinician went missing after going on an afternoon bike ride. Authorities found his body the following day. | | |
|
More and more clinicians are using advanced CCTA technologies to diagnose, treat and manage patients with suspected coronary artery disease. An upcoming webinar will include a deep dive into that very topic, highlighting why the modality is such a game-changer for patient care. More and more clinicians are using advanced CCTA technologies to diagnose, treat and manage patients with suspected coronary artery disease. An upcoming webinar will include a deep dive into that very topic, highlighting why the modality is such a game-changer for patient care. | | |
|
|
Clinicians have been using this device to perform M-TEER for years. After this latest announcement, it is now officially approved for both mitral valve repair and tricuspid valve repair. Clinicians have been using this device to perform M-TEER for years. After this latest announcement, it is now officially approved for both mitral valve repair and tricuspid valve repair. | | |
|
These pacemakers were built with conduction system pacing in mind, giving clinicians several new tools for the management of heart patients. These pacemakers were built with conduction system pacing in mind, giving clinicians several new tools for the management of heart patients. | | |
|
According to Elucid, the development of its FFR-IQ software was guided by clinician feedback. According to Elucid, the development of its FFR-IQ software was guided by clinician feedback. | | |
|
|
Once finalized, Counsel Health will see its technology integrated into the Oura application, with an emphasis on improving the management of chronic conditions and monitoring patients for acute emergencies, based on biometrics gathered by smart rings. Once finalized, Counsel Health will see its technology integrated into the Oura application, with an emphasis on improving the management of chronic conditions and monitoring patients for acute emergencies, based on biometrics gathered by smart rings. | | |
|
The state attorneys general argue that the Medicaid work requirements may be unconstitutional, in violation of governmental sovereignty, as they effectively transform the safety net healthcare program into something administered by the federal government. The state attorneys general argue that the Medicaid work requirements may be unconstitutional, in violation of governmental sovereignty, as they effectively transform the safety net healthcare program into something administered by the federal government. | | |
|